IL66270A0 - Cancer cell-combatting lymphocytes,their production and anticancer agents containing them - Google Patents

Cancer cell-combatting lymphocytes,their production and anticancer agents containing them

Info

Publication number
IL66270A0
IL66270A0 IL66270A IL6627082A IL66270A0 IL 66270 A0 IL66270 A0 IL 66270A0 IL 66270 A IL66270 A IL 66270A IL 6627082 A IL6627082 A IL 6627082A IL 66270 A0 IL66270 A0 IL 66270A0
Authority
IL
Israel
Prior art keywords
combatting
lymphocytes
production
cancer cell
anticancer agents
Prior art date
Application number
IL66270A
Other versions
IL66270A (en
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56156413A external-priority patent/JPS5857318A/en
Priority claimed from JP15641481A external-priority patent/JPS5857321A/en
Priority claimed from JP56158472A external-priority patent/JPS5859922A/en
Priority claimed from JP56158473A external-priority patent/JPS5859923A/en
Priority claimed from JP57111168A external-priority patent/JPS591420A/en
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of IL66270A0 publication Critical patent/IL66270A0/en
Priority to IL75524A priority Critical patent/IL75524A0/en
Publication of IL66270A publication Critical patent/IL66270A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
IL66270A 1981-10-01 1982-07-08 Cancer cell-derived glyco-related antigen,its production and anticancer agent containing it IL66270A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL75524A IL75524A0 (en) 1981-10-01 1985-06-14 Cancer cell-combating lymphocytes,their production and anticancer agents containing them

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP56156413A JPS5857318A (en) 1981-10-01 1981-10-01 Production of lymphocytes inhibiting cancer cells
JP15641481A JPS5857321A (en) 1981-10-01 1981-10-01 Anticancer agent
JP56158472A JPS5859922A (en) 1981-10-05 1981-10-05 Cancer cell-disturbing lymphocyte
JP56158473A JPS5859923A (en) 1981-10-05 1981-10-05 Carcinostatic agent
JP57111168A JPS591420A (en) 1982-06-28 1982-06-28 Sugar chain-relating antigen and its preparation

Publications (2)

Publication Number Publication Date
IL66270A0 true IL66270A0 (en) 1982-11-30
IL66270A IL66270A (en) 1986-03-31

Family

ID=27526479

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66270A IL66270A (en) 1981-10-01 1982-07-08 Cancer cell-derived glyco-related antigen,its production and anticancer agent containing it

Country Status (19)

Country Link
AR (1) AR230731A1 (en)
AT (2) AT382080B (en)
AU (1) AU554858B2 (en)
BE (1) BE893704A (en)
CA (1) CA1195269A (en)
CH (2) CH655660B (en)
DD (2) DD221917A5 (en)
DE (2) DE3236298A1 (en)
DK (1) DK292182A (en)
FI (1) FI77157C (en)
FR (1) FR2513882B1 (en)
IL (1) IL66270A (en)
IT (1) IT1189305B (en)
MX (1) MX7437E (en)
NL (1) NL8202638A (en)
NO (1) NO161601C (en)
NZ (1) NZ201112A (en)
PT (1) PT75148B (en)
SE (1) SE8204058L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214737A (en) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk Preparation of saccharide chain-related antigen (tca)
EP0334300A1 (en) * 1988-03-21 1989-09-27 Neorx Corporation The use of monoclonal antibodies and conjugates thereof as signals to direct sensitized effector cells to tumor sites

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1193378A (en) * 1967-04-11 1970-05-28 Rand Dev Corp Cancer Antigen Complexes
DE1943699A1 (en) * 1969-08-28 1971-03-04 Stiftung Onophrio Medicinal product with an anti-proliferation effect and process for the manufacture of this medicinal product
YU34005B (en) * 1970-02-24 1978-10-31 Podvinec Srecko Process for obtaining bovine lymphatic gland extract
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate

Also Published As

Publication number Publication date
FI822325A0 (en) 1982-06-29
SE8204058L (en) 1983-04-02
FI77157C (en) 1989-02-10
CH655660B (en) 1986-05-15
DE3249568A1 (en) 1985-02-07
NZ201112A (en) 1986-10-08
DE3236298A1 (en) 1984-03-15
FR2513882B1 (en) 1986-04-04
IL66270A (en) 1986-03-31
PT75148A (en) 1982-07-01
NL8202638A (en) 1983-05-02
AT390002B (en) 1990-03-12
FI77157B (en) 1988-10-31
DE3249568C2 (en) 1987-10-01
FI822325L (en) 1983-04-02
AU8545882A (en) 1983-04-14
BE893704A (en) 1982-10-18
DE3236298C2 (en) 1987-09-24
SE8204058D0 (en) 1982-06-30
ATA363782A (en) 1986-06-15
NO822215L (en) 1983-04-05
FR2513882A1 (en) 1983-04-08
AU554858B2 (en) 1986-09-04
CA1195269A (en) 1985-10-15
PT75148B (en) 1986-08-14
NO161601C (en) 1989-09-06
MX7437E (en) 1988-11-14
IT8248724A0 (en) 1982-06-30
AR230731A1 (en) 1984-06-29
DD209577A5 (en) 1984-05-16
DK292182A (en) 1983-04-02
AT382080B (en) 1987-01-12
CH655661B (en) 1986-05-15
IT1189305B (en) 1988-02-04
NO161601B (en) 1989-05-29
DD221917A5 (en) 1985-05-08
ATA354585A (en) 1989-08-15

Similar Documents

Publication Publication Date Title
JPS57179124A (en) Anticancer and preparation
DE3373817D1 (en) Oligonucleotide derivatives and production thereof
IL65056A0 (en) Imidazodiazepines,their manufacture and pharmaceutical compositions containing them
IL65167A (en) N-acyl-polypeptides,their production and pharmaceutical compositions containing them
ZA821421B (en) Platinum-diamine complexes,their preparation and use
SG78584G (en) W-cyano-1,w-diphenyl-azaalkane derivatives,their preparation,and drugs containing them
EP0088151A3 (en) Anticancer drugs
DE3267865D1 (en) Catalysts and their production
AR242389A1 (en) Imidazoquinazoline derivatives, their preparation and medicaments containing them
GB2106935B (en) Cancer cell-combatting lymphocytes process for the production thereof and anticancer agents containing said lymphocytes
ZA813387B (en) Chemical compounds,their production and their use in drugs
IL68576A0 (en) Azepinoindoles,their production and pharmaceutical compositions containing them
IL67284A (en) N-substituted-2-pyridylindoles,their manufacture and pharmaceutical compositions containing them
DE3163185D1 (en) Indene derivatives, their preparation and medicines containing them
DE3361924D1 (en) Polypeptide-diesters, their production and use
IL63323A (en) Pentapeptides,their production and pharmaceutical compositions containing them
IL67813A0 (en) Benzothienylallylamines,their production and pharmaceutical compositions containing them
PH18585A (en) Aminocyclitol derivatives,their preparation and medicaments
IL66270A0 (en) Cancer cell-combatting lymphocytes,their production and anticancer agents containing them
ZA832742B (en) 1-sulfo-2-azetidinone derivatives,their production and use
ZA824645B (en) Cancer cell-combatting lymphocytes,process for the production thereof and anticancer agents containing said lymphocytes
IL75524A0 (en) Cancer cell-combating lymphocytes,their production and anticancer agents containing them
IL63661A0 (en) 4-carbamoyloxy-oxazaphosphorins,their production and pharmaceutical preparations containing them
DE3267439D1 (en) Trifluoromethanesulfonanilides, and their production and use
PH22474A (en) Cancer cell-combatting lymphocytes, process for the production thereof and anticancer agents containing said lymphocytes